Magnetoliposomes may be useful for elimination of HIV from infected individuals.
A simple method is proposed for the treatment of the acquired immunodeficiency syndrome (AIDS) by introducing into the blood stream magnetoliposomes with coupled human immunodeficiency virus (HIV) receptor proteins. After some time lag, needed for binding of HIV and HIV-infected cells to magnetoliposomes, the arterio-venous shunt, as used with dialysis patients should be inserted and the patient's blood should be passed through multiple tubes filled with stainless steel wool, each of which is surrounded by a coil producing a strong non-homogeneous magnetic field, which may result in a substantial reduction of HIV and HIV-infected cells in the infected body.
Babincová
M
M
Department of Biophysics and Chemical Physics, Comenius University, Bratislava, Slovakia. babincova@fmph.uniba.sk
Machová
E
E
D000163:Acquired Immunodeficiency Syndrome / Q000628:therapy* / Q000821:virology; D052203:Ferrosoferric Oxide; D006678:HIV / Q000302:isolation & purification*; D015658:HIV Infections / Q000628:therapy* / Q000821:virology; D006801:Humans; D007501:Iron; D008081:Liposomes; D010087:Oxides
D008081:Liposomes; D010087:Oxides; D007501:Iron; D052203:Ferrosoferric Oxide